Micro-X Limited (ASX:MX1)
0.0430
+0.0020 (4.88%)
Oct 27, 2026, 3:47 PM AEDT
Micro-X Market Cap
Micro-X has a market cap or net worth of 32.35 million as of October 27, 2026. It is the 36,113th most valuable company in the world and the 922nd biggest in Australia. Its market cap has decreased by 53.86% in one year.
Market Cap
32.35M
Enterprise Value
35.70M
Revenue
15.09M
Global Rank
Country Rank
#922 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 22, 2015, Micro-X's market cap has decreased from 71.65M to 32.35M, a decrease of -54.84%. That is a compound annual growth rate of -7.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 39.13M | -48.52% |
| Dec 31, 2025 | 76.00M | 55.15% |
| Dec 31, 2024 | 48.98M | -9.95% |
| Dec 29, 2023 | 54.40M | -18.58% |
| Dec 30, 2022 | 66.81M | -43.06% |
| Dec 31, 2021 | 117.33M | -8.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saluda Medical | 63.01M |
| Lumos Diagnostics Holdings | 62.19M |
| Epiminder | 57.42M |
| Cyclopharm | 46.52M |
| Compumedics | 45.95M |
| Nova Eye Medical | 45.59M |
| HeraMED | 45.19M |
| Cleo Diagnostics | 40.45M |